Goldman Sachs’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,298	Closed	-$4K	–	6767
2022 Q2	$4K	Sell	12,298 -495,892	-98%	-$251K	﹤0.01%	6371
2022 Q1	$346K	Sell	508,190 -285	-0.1%	-$313	﹤0.01%	5588
2021 Q4	$1.18M	Buy	508,475 +466,289	+1,105%	+$1.58M	﹤0.01%	4704
2021 Q3	$193K	Sell	42,186 -12,844	-23%	-$56.5K	﹤0.01%	5734
2021 Q2	$244K	Buy	55,030 +20,423	+59%	+$104K	﹤0.01%	5640
2021 Q1	$252K	Buy	34,607 +4,317	+14%	+$35.5K	﹤0.01%	5517
2020 Q4	$231K	Buy	30,290 +976	+3%	+$6.53K	﹤0.01%	5017
2020 Q3	$266K	Sell	29,314 -10,323	-26%	-$78.3K	﹤0.01%	4797
2020 Q2	$335K	Buy	39,637 +13,567	+52%	+$89.3K	﹤0.01%	4574
2020 Q1	$129K	Buy	26,070 +898	+4%	+$6.98K	﹤0.01%	4880
2019 Q4	$181K	Buy	25,172 +1,480	+6%	+$13.4K	﹤0.01%	4921
2019 Q3	$256K	Buy	+23,692	New	+$253K	﹤0.01%	4739
2019 Q1	–	Sell	-64,949	Closed	-$675K	–	5555
2018 Q4	$675K	Buy	+64,949	New	+$785K	﹤0.01%	4204